636 related articles for article (PubMed ID: 25591123)
1. Indications and limitations of bariatric intervention in severely obese children and adolescents with and without nonalcoholic steatohepatitis: ESPGHAN Hepatology Committee Position Statement.
Nobili V; Vajro P; Dezsofi A; Fischler B; Hadzic N; Jahnel J; Lamireau T; McKiernan P; McLin V; Socha P; Tizzard S; Baumann U
J Pediatr Gastroenterol Nutr; 2015 Apr; 60(4):550-61. PubMed ID: 25591123
[TBL] [Abstract][Full Text] [Related]
2. Bariatric Surgery Reduces Features of Nonalcoholic Steatohepatitis in Morbidly Obese Patients.
Lassailly G; Caiazzo R; Buob D; Pigeyre M; Verkindt H; Labreuche J; Raverdy V; Leteurtre E; Dharancy S; Louvet A; Romon M; Duhamel A; Pattou F; Mathurin P
Gastroenterology; 2015 Aug; 149(2):379-88; quiz e15-6. PubMed ID: 25917783
[TBL] [Abstract][Full Text] [Related]
3. Features of nonalcoholic steatohepatitis in severely obese children and adolescents undergoing sleeve gastrectomy.
Alqahtani A; Elahmedi M; Alswat K; Arafah M; Fagih M; Lee J
Surg Obes Relat Dis; 2017 Sep; 13(9):1599-1609. PubMed ID: 28600116
[TBL] [Abstract][Full Text] [Related]
4. The role of bariatric surgery in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
Shouhed D; Steggerda J; Burch M; Noureddin M
Expert Rev Gastroenterol Hepatol; 2017 Sep; 11(9):797-811. PubMed ID: 28712339
[TBL] [Abstract][Full Text] [Related]
5. Histologic improvement of NAFLD in patients with obesity after bariatric surgery based on standardized NAS (NAFLD activity score).
von Schönfels W; Beckmann JH; Ahrens M; Hendricks A; Röcken C; Szymczak S; Hampe J; Schafmayer C
Surg Obes Relat Dis; 2018 Oct; 14(10):1607-1616. PubMed ID: 30146425
[TBL] [Abstract][Full Text] [Related]
6. Surgical treatment of non-alcoholic steatohepatitis and non-alcoholic fatty liver disease.
Weiner RA
Dig Dis; 2010; 28(1):274-9. PubMed ID: 20460923
[TBL] [Abstract][Full Text] [Related]
7. Bariatric Surgery Provides Long-term Resolution of Nonalcoholic Steatohepatitis and Regression of Fibrosis.
Lassailly G; Caiazzo R; Ntandja-Wandji LC; Gnemmi V; Baud G; Verkindt H; Ningarhari M; Louvet A; Leteurtre E; Raverdy V; Dharancy S; Pattou F; Mathurin P
Gastroenterology; 2020 Oct; 159(4):1290-1301.e5. PubMed ID: 32553765
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of nonalcoholic steatohepatitis in Japanese patients with morbid obesity undergoing bariatric surgery.
Seki Y; Kakizaki S; Horiguchi N; Hashizume H; Tojima H; Yamazaki Y; Sato K; Kusano M; Yamada M; Kasama K
J Gastroenterol; 2016 Mar; 51(3):281-9. PubMed ID: 26314837
[TBL] [Abstract][Full Text] [Related]
9. Roux-en-Y gastric bypass versus adjustable gastric banding to reduce nonalcoholic fatty liver disease: a 5-year controlled longitudinal study.
Caiazzo R; Lassailly G; Leteurtre E; Baud G; Verkindt H; Raverdy V; Buob D; Pigeyre M; Mathurin P; Pattou F
Ann Surg; 2014 Nov; 260(5):893-8; discussion 898-9. PubMed ID: 25379859
[TBL] [Abstract][Full Text] [Related]
10. Bariatric surgery in severely obese adolescents improves major comorbidities including hyperuricemia.
Oberbach A; Neuhaus J; Inge T; Kirsch K; Schlichting N; Blüher S; Kullnick Y; Kugler J; Baumann S; Till H
Metabolism; 2014 Feb; 63(2):242-9. PubMed ID: 24332707
[TBL] [Abstract][Full Text] [Related]
11. The role of bariatric surgery in the management of nonalcoholic fatty liver disease and metabolic syndrome.
Aguilar-Olivos NE; Almeda-Valdes P; Aguilar-Salinas CA; Uribe M; Méndez-Sánchez N
Metabolism; 2016 Aug; 65(8):1196-207. PubMed ID: 26435078
[TBL] [Abstract][Full Text] [Related]
12. Recent concepts of pharmacotherapy and bariatric surgery for childhood obesity: an overview.
Gogakos A; Tzotzas TC; Krassas GE
Pediatr Endocrinol Rev; 2009 Dec; 7(2):3-14. PubMed ID: 20118889
[TBL] [Abstract][Full Text] [Related]
13. Bariatric surgery as potential treatment for nonalcoholic fatty liver disease: a future treatment by choice or by chance?
Hafeez S; Ahmed MH
J Obes; 2013; 2013():839275. PubMed ID: 23431426
[TBL] [Abstract][Full Text] [Related]
14. PNPLA3 genotype increases susceptibility of nonalcoholic steatohepatitis among obese patients with nonalcoholic fatty liver disease.
Tai CM; Huang CK; Tu HP; Hwang JC; Chang CY; Yu ML
Surg Obes Relat Dis; 2015; 11(4):888-94. PubMed ID: 25240529
[TBL] [Abstract][Full Text] [Related]
15. Liver fat deposition and mitochondrial dysfunction in morbid obesity: An approach combining metabolomics with liver imaging and histology.
Calvo N; Beltrán-Debón R; Rodríguez-Gallego E; Hernández-Aguilera A; Guirro M; Mariné-Casadó R; Millá L; Alegret JM; Sabench F; del Castillo D; Vinaixa M; Rodríguez MÀ; Correig X; García-Álvarez R; Menendez JA; Camps J; Joven J
World J Gastroenterol; 2015 Jun; 21(24):7529-44. PubMed ID: 26140000
[TBL] [Abstract][Full Text] [Related]
16. The effect of surgically induced weight loss on nonalcoholic fatty liver disease in morbidly obese Indians: "NASHOST" prospective observational trial.
Praveen Raj P; Gomes RM; Kumar S; Senthilnathan P; Karthikeyan P; Shankar A; Palanivelu C
Surg Obes Relat Dis; 2015; 11(6):1315-22. PubMed ID: 26003897
[TBL] [Abstract][Full Text] [Related]
17. Bariatric surgery improves nonalcoholic fatty liver disease: a contemporary systematic review and meta-analysis.
Fakhry TK; Mhaskar R; Schwitalla T; Muradova E; Gonzalvo JP; Murr MM
Surg Obes Relat Dis; 2019 Mar; 15(3):502-511. PubMed ID: 30683512
[TBL] [Abstract][Full Text] [Related]
18. HSCRP as surrogate marker in predicting long term effect of bariatric surgery on resolution of non-alcoholic steatohepatitis.
Tan CH; Al-Kalifah N; Lee WJ; Ser KH; Lee YC; Chen JC
Asian J Surg; 2019 Jan; 42(1):203-208. PubMed ID: 29804707
[TBL] [Abstract][Full Text] [Related]
19. Bariatric surgery for non-alcoholic fatty liver disease in individuals with obesity (Base-NAFLD): protocol of a prospective multicenter observational follow-up study.
Wei L; Li M; Zeng N; Liu Y; Bai R; Zhang N; Song J; Zhang P; Yao Q; Yang Z; Zhao X; Zhang Y; Zhang P; Zhang Z
BMC Surg; 2021 Jun; 21(1):298. PubMed ID: 34167531
[TBL] [Abstract][Full Text] [Related]
20. Effects of bariatric surgery on nonalcoholic fatty liver disease: preliminary findings after 2 years.
Furuya CK; de Oliveira CP; de Mello ES; Faintuch J; Raskovski A; Matsuda M; Vezozzo DC; Halpern A; Garrido AB; Alves VA; Carrilho FJ
J Gastroenterol Hepatol; 2007 Apr; 22(4):510-4. PubMed ID: 17376042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]